Table 2.
Glycemic control parameters and length of in-hospital stay.
| Study identification | A1c (%) | BG within the target range (%) | Mean BG (mg/dL) | Reduçtion of mean BG | Frequency of hyperglicemia (%) (mg/dL) | Frequency of hypoglycemia (mg/dL) (%) | Lenght of in-hospital stay (days) |
|---|---|---|---|---|---|---|---|
| Study #1: Schnipper32 | Pre-intervention: 8.5Post-intervention: 8.3 | 65.0 (p = 0.04) | 165 | 5.78 | No data | <60 mg/dL: 6.1<40 mg/dL: 1.2 (patients-day) | Pre-intervention: 4.6Post-intervention: 3.5 |
| Study #2: Maynard37 | No data | 69.9 (p < 0.005) | 165 ± 58 | 7.82 | No data | <60 mg/dL: 9.8<40 mg/dL: 2.4 (patients-day) | Pre-intervention: 4.6Post-intervention: 4.8 |
| Study #3: Murphy38 | No data | Pre-intervention: 66Post-intervention: 53 | <135 | 15 | No data | <60 mg/dL: 6 | No data |
| Study #4:Wexler33 | No data | No data | Intervention: 194 ± 66Control: 224 ± 57 | No data | Intervention: 26Control: 38 BG > 240 mg/dL) | Intervention: <60 mg/dL: 12<40 mg/dL: 0Control: <60 mg/dL: 14<40 mg/dL: 1 | Intervention: 6Control: 5 |
| Study #5:Schnipper34 | Intervention: 7.6 ± 2.4Control: 7.4 ± 1.6 | Intervention: 74.6 (p = 0.05)Control: 71.3 | Intervention: 148 ± 42Control: 158 ± 54 | No data | Intervention: 7.3Control: 14.8(BG > 300 mg/dL) | Intervention: <60:mg/dL 6.8<40 mg/dL: 0.5Control: <60 mg/dL: 3.5<40 mg/dL: 0.3 (patients-day) | Intervention: 6.2Control: 5.7 |
| Study #6: Neubauer35 | 8.1 ± 4.1 | 50.2 (p = 0.001) | 154 ± 35 | No data | No data | 60–70 mg/dL:1.440–60 mg/dL: 0.5 <40 mg/dL: 0 | No data |
| Study #7: Gregory36 | T1DM: 9.3 ± 2.7T2DM2: 7.7 ± 2.0 | Pre-intervention: 65.7Post-intervention: 56.9 | No data | No data | Pre-intervention: 31.8Post-intervention: 41.3 | <70 mg/dL:1.8 | No data |
T1DM1, Type 1 Diabetes mellitus; T2DM, Type 2 Diabetes mellitus; BG, blood glucose; A1c, glycated hemoglobin.